title: Eligibility for home oxygen programs and funding across Canada.
abstract: BACKGROUND
  In Canada, although medical insurance is generally universal, significant differences exist in the provision of home oxygen therapy across the country.
  
  
  OBJECTIVE
  To systematically compare the terms of reference for home oxygen across Canada, with a focus on the clinical inclusion criteria to the programs.
  
  
  METHODS
  The authors searched the terms of reference of the 10&nbsp;Canadian provinces and three territories, focusing on general eligibility criteria for home oxygen (including blood gas criteria, and eligibility criteria for ambulatory and nocturnal oxygen), and compared the eligibility criteria to the widely accepted criteria of the Nocturnal Oxygen Therapy Trial (NOTT) trial, the clinical recommendations of the Canadian Thoracic Society and the results of Cochrane reviews.
  
  
  RESULTS
  The terms of reference for nine provinces were retrieved. All jurisdictions have similar criteria for long-term oxygen therapy, with slight differences in the thresholds of prescription and the clinical criteria defining 'pulmonary hypertension' or 'cor pulmonale'. The use of oxyhemoglobin saturation as a criterion for funding is inconsistent. All nine provinces fund nocturnal oxygen, all with different clinical criteria. Funding for portable oxygen widely varies across provinces, whether the ambulatory equipment is offered to patients on long-term oxygen therapy or to those who have isolated exercise-induced desaturation. The terms of reimbursement are very heterogeneous.
  
  
  CONCLUSIONS
  Heterogeneity exists in the criteria for eligibility to home oxygen programs and funding across Canada. Terms of prescription and reimbursement of oxygen are not necessarily supported by available evidence from the current literature in several Canadian jurisdictions.
authors: Yves
authors: Y
authors: Lacasse
authors: Sarah
authors: S
authors: Bernard
authors: François
authors: F
authors: Maltais
mesh_terms: D002170:Canada; D004608:Eligibility Determination / Q000379:methods*; D006801:Humans; D019458:Insurance Coverage / Q000191:economics*; D010102:Oxygen Inhalation Therapy / Q000191:economics / Q000379:methods*; D029424:Pulmonary Disease, Chronic Obstructive / Q000628:therapy*